Mostrar el registro sencillo del ítem
Synthesis and antiproliferative effect of ethyl 4-[4-(4-substituted piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate derivatives on human leukemia cells
hal.structure.identifier | Cellules souches hématopoïétiques normales et leucémiques | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
dc.contributor.author | DESPLAT, Vanessa | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Department of Pharmacy and CIRPeB | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | VINCENZI, Marian | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | LUCAS, Romain | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | MOREAU, Stéphane | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | SAVRIMOUTOU, Solène | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | RUBIO, Sandra | |
hal.structure.identifier | Institut des Sciences Moléculaires [ISM] | |
dc.contributor.author | PINAUD, Noël | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | BIGAT, David | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | ENRIQUEZ, Elodie | |
hal.structure.identifier | Institut de Chimie de la Matière Condensée de Bordeaux [ICMCB] | |
dc.contributor.author | MARCHIVIE, Mathieu | |
hal.structure.identifier | Institut de Chimie Organique et Analytique [ICOA] | |
dc.contributor.author | ROUTIER, Sylvain | |
hal.structure.identifier | Laboratoire de Glycochimie, des Antimicrobiens et des Agro-ressources - UMR CNRS 7378 [LG2A ] | |
dc.contributor.author | SONNET, Pascal | |
hal.structure.identifier | Department of Pharmacy and CIRPeB | |
dc.contributor.author | ROSSI, Filomena | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | RONGA, Luisa | |
hal.structure.identifier | UFR des Sciences Pharmaceutiques | |
hal.structure.identifier | Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA] | |
dc.contributor.author | GUILLON, Jean | |
dc.date.issued | 2017-06-21 | |
dc.identifier.issn | 1860-7179 | |
dc.description.abstractEn | Acute leukemia is a hematological malignancy with high incidence and recurrence rates and is characterized by an accumulation of blasts in bone marrow due to proliferation of immature lymphoid or myeloid cells associated with a blockade of differentiation. The heterogeneity of leukemia led us to look for new specific molecules for leukemia subtypes or for therapy-resistant cases. Among heterocyclic derivatives that attracted attention due to their wide range of biological activities, we focused our interest on the pyrrolo[1,2-a]quinoxaline heterocyclic framework that has been previously identified as an interesting scaffold for antiproliferative activities against various human cancer cell lines. In this work, new ethyl 4-[4-(4-substituted piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate derivatives (1 a-o) were designed, synthesized, and evaluated against five different leukemia cell lines, including Jurkat and U266 (lymphoid cell lines) and K562, U937, and HL60 (myeloid cell lines), as well as on normal human peripheral blood mononuclear cells (PBMCs). This new pyrrolo[1,2-a]quinoxaline series showed interesting cytotoxic potential against all tested leukemia cell lines. In particular, pyrroloquinoxalines 1 a and 1 m,n seem to be interesting due to their high activity against leukemia and their low activity against normal hematopoietic cells, leading to a high index of selectivity. | |
dc.language.iso | en | |
dc.publisher | Wiley-VCH Verlag | |
dc.subject.en | anticancer agents | |
dc.subject.en | cytotoxic activity | |
dc.subject.en | leukemia | |
dc.subject.en | pyrrolo[1 | |
dc.subject.en | 2-a]quinoxalines | |
dc.subject.en | synthesis | |
dc.title.en | Synthesis and antiproliferative effect of ethyl 4-[4-(4-substituted piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate derivatives on human leukemia cells | |
dc.type | Article de revue | |
dc.identifier.doi | 10.1002/cmdc.201700049 | |
dc.subject.hal | Chimie/Matériaux | |
bordeaux.journal | ChemMedChem | |
bordeaux.page | 940-953 | |
bordeaux.volume | 12 | |
bordeaux.issue | 12 | |
bordeaux.peerReviewed | oui | |
hal.identifier | hal-01560237 | |
hal.version | 1 | |
hal.popular | non | |
hal.audience | Internationale | |
hal.origin.link | https://hal.archives-ouvertes.fr//hal-01560237v1 | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=ChemMedChem&rft.date=2017-06-21&rft.volume=12&rft.issue=12&rft.spage=940-953&rft.epage=940-953&rft.eissn=1860-7179&rft.issn=1860-7179&rft.au=DESPLAT,%20Vanessa&VINCENZI,%20Marian&LUCAS,%20Romain&MOREAU,%20St%C3%A9phane&SAVRIMOUTOU,%20Sol%C3%A8ne&rft.genre=article |
Archivos en el ítem
Archivos | Tamaño | Formato | Ver |
---|---|---|---|
No hay archivos asociados a este ítem. |